Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2019

Oct 14, 2019

60507_rns_2019-10-14_041b2494-2245-4859-aa0b-66db1c9c3d62.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [66 x 38] intentionally omitted <==

==> picture [185 x 23] intentionally omitted <==

KCPL/PFZ/SEP/2019 October 11, 2019

Mr. Prajeet Nair Company Secretary M/s. Pfizer Limited The Capital, 1802/1901 Plot C-70 G Block, BandraKurla Complex Bandra East, Mumbai- 400051

Sub : Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Dear Sir/Madam,

Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended September 30, 2019, were confirmed (accepted / rejected) to the depositories by us and the securities comprised in the said certificates have been listed on stock exchanges where the earlier issued securities are listed.

We also hereby confirm that the security certificates received for dematerialisation have been mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as the registered owner within 30 days.

Request to kindly take the above on record

Thanking You

Yours faithfully, for KARVY FINTECH PRIVATE LIMITED

==> picture [50 x 25] intentionally omitted <==

M R V SUBRAHMANYAM General Manager

==> picture [157 x 13] intentionally omitted <==

KARVY FINTECH PRIVATE LIMITED (KFPL) (Formerly known as KCPL Advisory Services Private Limited) Registered & Corporate Office